This award goes to a product that stands out as a major disruption to the practice of gastroenterology.

This award goes to a patient advocate or advocacy group that moved the needle on a disease in regard to discussion in the public sphere, better communication between patients and providers and/or advocacy for legislative or regulatory action (drug approvals, insurance coverage, etc).

This award goes to a woman in the field who has emerged as a leader and as an example to younger women of how a successful career can unfold.

This award goes to a physician who has made meaningful change to overcome the social determinants of health in gastroenterology. The awardee is seen as a model of how identifying and addressing social determinants of health can better patient care.

This award goes to an up-and-coming physician who is already disrupting the status quo in the field whether it be through new techniques, new thoughts, questioning methods or breakthrough research.

This award goes to a gastroenterologist or hepatologist who consistently pushed the gastroenterology field forward through innovative treatments, practice management, patient care or research.

This award goes to a physician or institution that changed the face of the gastroenterology practice.

This award goes to a health care professional who makes a positive impact on social media and led the tidal change in health care provider use within gastroenterology.

During the ACG Annual Meeting, I was happy to honor our 2021 Healio Disruptive Innovators. This was the Fourth Healio Disruptive Innovators Awards ceremony.

In this video exclusive from the ACG Scientific Annual Meeting, Amit Singal, MD, from UT Southwestern Medical Center, discussed best practices for the screening, surveillance, and treatment of hepatocellular carcinoma.